Drugs Looking for Diseases

Abstract Theoretical Practical

[1]  D Schwartzman.  "Innovation in the Pharmaceutical Industry". , 1978, British medical journal.

[2]  J. Telleria.  [Mechanism of muscular contraction]. , 1951, Medicina.

[3]  Kenneth F. Schaffner,et al.  DISCOVERY IN THE BIOMEDICAL SCIENCES: LOGIC OR IRRATIONAL INTUITION?· , 1980 .

[4]  R. Beamish,et al.  Impending myocardial infarction. Recognition and management. , 1960 .

[5]  P. M. Lish,et al.  Effect of some new beta-adrenergic blocking agents on certain metabolic responses to catecholamines. , 1965, Journal of Pharmacology and Experimental Therapeutics.

[6]  O. Kraupp.  [On the mechanism of action of coronary dilators]. , 1969, Naunyn-Schmiedebergs Archiv fur experimentelle Pathologie und Pharmakologie.

[7]  R. Bing,et al.  Effect of nitroglycerin, intensain, isoptin and papaverine on coronary blood flow in man. Measured by the coincidence counting technic and rubidium. , 1966, The American journal of cardiology.

[8]  R. Macalpin,et al.  Angina Pectoris at Rest with Preservation of Exercise Capacity: Prinzmetal's Variant Angina , 1973, Circulation.

[9]  A. Caplan.  Exemplary reasoning? A comment on theory structure in biomedicine. , 1986, The Journal of medicine and philosophy.

[10]  N. Moran.  Pharmacological characterization of adrenergic receptors. , 1966, Pharmacological reviews.

[11]  Gernot Böhme,et al.  Die gesellschaftliche Orientierung des wissenschaftlichen Fortschritts , 1978 .

[12]  S. Chierchia,et al.  Significance of spasm in the pathogenesis of ischemic heart disease. , 1979, The American journal of cardiology.

[13]  E. Hemminki.  Study of information submitted by drug companies to licensing authorities. , 1980, British medical journal.

[14]  C. Mulrow,et al.  Reevaluation of digitalis efficacy. New light on an old leaf. , 1984, Annals of internal medicine.

[15]  D. Sabiston,et al.  Current Research and Problems of the Coronary Circulation , 1956, Circulation.

[16]  Drugs in the management of angina pectoris. , 1969 .

[17]  A. Atkinson,et al.  The pharmacological basis of therapeutics. 6th ed: By Alfred Goodman Gilman, Louis S. Goodman, and Alfred Gilman. 1843 pp., $45.00. Macmillan Publishing Co., Inc., New York, New York, 1980 , 1981 .

[18]  Theo A.F. Kuipers,et al.  Approaching descriptive and theoretical truth , 1982 .

[19]  N C MORAN,et al.  Adrenergic blockade of the mammalian heart by a dichloro analogue of isoproterenol. , 1958, The Journal of pharmacology and experimental therapeutics.

[20]  R. Maxwell.  The state of the art of the science of drug discovery—an opinion , 1984 .

[21]  Stig Andur Pedersen,et al.  Philosophy of Medicine , 1986 .

[22]  P. Fildes.  A RATIONAL APPROACH TO RESEARCH IN CHEMOTHERAPY , 1940 .

[23]  B. Lucchesi,et al.  The influence of dichloroiso-proterenol (DCI) and related compounds upon ouabain and acetylstrophanthidin induced cardiac arrhythmias. , 1961, The Journal of pharmacology and experimental therapeutics.

[24]  H H Dale,et al.  Chemical structure and sympathomimetic action of amines , 1910, The Journal of physiology.

[25]  S. Mellander,et al.  Quantitative aspects of the sympathetic neuro-hormonal control of the heart rate. , 1956, Acta physiologica Scandinavica.

[26]  N. R. Hanson.  Perception and discovery , 1969 .

[27]  S. Spicker,et al.  Clinical Judgment: A Critical Appraisal , 1979 .

[28]  M. Kaltenbach,et al.  Calciumantagonistische Therapie bei hypertroph-obstruktiver Kardiomyopathie , 1976 .

[29]  B. Singh,et al.  A third class of anti‐arrhythmic action. Effects on atrial and ventricular intracellular potentials, and other pharmacological actions on cardiac muscle, of MJ 1999 and AH 3474 , 1970, British journal of pharmacology.

[30]  Mike Saren,et al.  A classification and review of models of the intra-firm innovation process , 1984 .

[31]  H. Beecher.  Clinical impression and clinical investigation. , 1953, Journal of the American Medical Association.

[32]  F. Sebening,et al.  [Coronary artery disease]. , 1980, Verhandlungen der Deutschen Gesellschaft fur Herz- und Kreislaufforschung.

[33]  D. Krikler,et al.  Immediate Effects of Intravenous Verapamil in Cardiac Arrhythmias , 1972, British medical journal.

[34]  G. Pickering.  Starling and the Concept of Heart Failure , 1960, Circulation.

[35]  Action theory as a source for philosophy of medicine , 1981 .

[36]  P. Dresel,et al.  Blockade of some cardiac actions of adrenaline by dichloroisoproterenol. , 1960, Canadian journal of biochemistry and physiology.

[37]  B. Levy,et al.  An analysis of selective beta receptor blockade. , 1969, European journal of pharmacology.

[38]  S. Stephen.  Unwanted effects of propranolol. , 1966, The American journal of cardiology.

[39]  John Metcalfe,et al.  A theoretical approach to the construction of technological output indicators , 1984 .

[40]  J. Shaver,et al.  Pharmacologic Interventions in Angina , 1986 .

[41]  E. Braunwald.  Coronary artery spasm as a cause of myocardial ischemia. , 1981, The Journal of laboratory and clinical medicine.

[42]  D. Zipes,et al.  Amiodarone, Aprindine, Disopyramide, Ethmozin, Mexiletine, Tocainide, Verapamil , 1978 .

[43]  K. I. Melville,et al.  IPROVERATRIL: EXPERIMENTAL DATA ON CORONARY DILATATION AND ANTIARRHYTHMIC ACTION. , 1964, Canadian Medical Association journal.

[44]  R. Vakil.  Intermediate Coronary Syndrome , 1961, Circulation.

[45]  L. Becker,et al.  Pathogenesis of angina pectoris. , 1982, Archives of internal medicine.

[46]  W. Nayler.  Calcium exchange in cardiac muscle: a basic mechanism of drug action. , 1967, American heart journal.

[47]  C. Friedberg,et al.  Introduction: Some Comments and Reflections on Changing Interests and New Developments in Angina Pectoris , 1972, Circulation.

[48]  J. H. Comroe,et al.  Scientific basis for the support of biomedical science. , 1976, Science.

[49]  D. Chamberlain,et al.  THE HÆMODYNAMIC EFFECTS OF β-SYMPATHETIC BLOCKADE , 1964 .

[50]  W. Raab.  Myocardial metabolism in the pathogenesis and treatment of angina pectoris. , 1953, Cardiologia.

[51]  John Weiner,et al.  Letter to the Editor , 1992, SIGIR Forum.

[52]  M. Winbury.  EXPERIMENTAL APPROACHES TO THE DEVELOPMENT OF ANTIANGINAL DRUGS. , 1964, Advances in pharmacology.

[53]  R. Ahlquist,et al.  A study of the adrenotropic receptors. , 1948, The American journal of physiology.

[54]  A. Maseri,et al.  Management of unstable angina at rest by verapamil. A double-blind cross-over study in coronary care unit. , 1979, British heart journal.

[55]  J. Stock,et al.  Beta-adrenergic Receptor Blockade in Cardiac Arrhythmias , 1963, British medical journal.

[56]  B. Prichard.  Hypotensive Action of Pronethalol , 1964, British medical journal.

[57]  A. Luisada,et al.  DOUBLE BLIND EVALUATION OF ORALLY ADMINISTERED IPROVERATRIL IN PATIENTS WITH ANGINA PECTORIS , 1966, The American journal of the medical sciences.

[58]  M. Silver,et al.  Prinzmetal's variant form of angina with arteriographic evidence of coronary arterial spasm. , 1972, The American journal of cardiology.

[59]  M. Nickerson.  Blockade of the actions of adrenaline and noradrenaline. , 1959, Pharmacological reviews.

[60]  A. Fleckenstein.  Calcium antagonism in heart and smooth muscle: Experimental facts and therapeutic prospects , 1983 .

[61]  Arthur Grishman.  Funktionsdiagnostik des gesunden und kranken herzens , 1967 .

[62]  T. Preston.  Coronary Artery Surgery: A Critical Review , 1977 .

[63]  J. Mcmichael.  CHANGING VIEWS ON HEART FAILURE , 1959 .

[64]  S. Chierchia,et al.  Mixed angina pectoris. , 1985, The American journal of cardiology.

[65]  Herbert A. Simon,et al.  Scientific discovery: compulalional explorations of the creative process , 1987 .

[66]  D. Phear.  Verapamil in angina: a double-blind trial. , 1968, British medical journal.

[67]  A. Selzer,et al.  Clinical syndrome of variant angina with normal coronary arteriogram. , 1976, The New England journal of medicine.

[68]  H. Grendahl,et al.  The Effect of Propranolol and Verapamil On Atrial and Atrioventricular Refractory Periods in Man , 1975, Angiology.

[69]  W. Aronow.  Management of stable angina. , 1973, The New England journal of medicine.

[70]  R. Burkhardt,et al.  Controlled clinical trials and medical ethics. , 1978, Lancet.

[71]  G E PAGET,et al.  Carcinogenic Action of Pronethalol , 1963, British medical journal.

[72]  J. Roberts,et al.  A method for the evaluation of depressants of subatrial rhythmic function in the heart of the intact animal. , 1960, The Journal of pharmacology and experimental therapeutics.

[73]  J. Black,et al.  A NEW ADRENERGIC BETARECEPTOR ANTAGONIST. , 1964, Lancet.

[74]  E. Braunwald,et al.  Mechanism of action of calcium-channel-blocking agents. , 1982, The New England journal of medicine.

[75]  C. Cavallito.  Some relationships between chemical structure and pharmacological activities. , 1968, Annual Review of Pharmacology.

[76]  J. R. Schmid,et al.  Antiarrhythmic actions of coronary vasodilator agents papaverine, dioxyline and verapamil. , 1970, Archives internationales de pharmacodynamie et de therapie.

[77]  Towards a cognitive model for technology-oriented R&D processes , 1988 .

[78]  G. Johnsson,et al.  Potency and time-effect relationship in man of propranolol and H 56-28--comparative studies after oral administration. , 2009, Acta pharmacologica et toxicologica.

[79]  M. Meier.  Effects of oxprenolol on cardiac contractile force, heart rate and coronary circulation. , 1970, Postgraduate medical journal.

[80]  P. Gillam,et al.  Use of Propranolol in Angina Pectoris , 1965, British medical journal.

[81]  D. Armstrong.  Clinical sense and clinical science. , 1977, Social science & medicine.

[82]  B. Folkow.  Impulse frequency in sympathetic vasomotor fibres correlated to the release and elimination of the transmitter. , 1952, Acta physiologica Scandinavica.

[83]  W. Proudfit,et al.  Physical signs during angina pectoris , 1968 .

[84]  F. Kline,et al.  Decision making in drug research , 1983 .

[85]  Raymond P. AHLQUlSTf.  ADRENERGIC RECEPTORS: A PERSONAL AND PRACTICAL VIEW* , 1973 .

[86]  R. Gorlin.  Pathophysiology of Cardiac Pain , 1965, Circulation.

[87]  B. Levy.  DIMETHYL ISOPROPYLMETHOXAMINE: A SELECTIVE β‐RECEPTOR BLOCKING AGENT , 1966 .

[88]  R. Shanks.  The effect of propranolol on the cardiovascular responses to isoprenaline, adrenaline and noradrenaline in the anaesthetized dog. , 1966, British journal of pharmacology and chemotherapy.

[89]  G. Jolles,et al.  Drug design : fact or fantasy? , 1984 .